Semaglutide reduces the risk of major adverse cardiovascular events consistently across baseline triglyceride levels in patients with type 2 diabetes: Post hoc analyses of the <scp>SUSTAIN</scp> 6 and <scp>PIONEER</scp> 6 trials-Reference-Cited by-同舟云学术

Semaglutide reduces the risk of major adverse cardiovascular events consistently across baseline triglyceride levels in patients with type 2 diabetes: Post hoc analyses of the SUSTAIN 6 and PIONEER 6 trials

Published:2023-05-03 Issue:8 Volume:25 Page:2388-2392
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obesity Metabolism

Author:

Verma Subodh¹^ORCID,David Jens‐Peter²,Leiter Lawrence A.³,Michelsen Marie Mide²,Rasmussen Søren²,Bhatt Deepak L.⁴^ORCID

Affiliation:

1. St. Michael's Hospital of Unity Health Toronto Toronto Ontario Canada

2. Novo Nordisk A/S Søborg Denmark

3. Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto Toronto Ontario Canada

4. Mount Sinai Heart Icahn School of Medicine at Mount Sinai New York New York USA

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference13 articles.

1. Remnant Cholesterol and Myocardial Infarction in Normal Weight, Overweight, and Obese Individuals from the Copenhagen General Population Study

2. High Triglycerides Are Associated With Increased Cardiovascular Events, Medical Costs, and Resource Use: A Real‐World Administrative Claims Analysis of Statin‐Treated Patients With High Residual Cardiovascular Risk

3. Triglyceride reduction in secondary atherosclerotic cardiovascular disease prevention: core concepts in contemporary therapeutic targeting

4. Triglycerides and Cardiovascular Outcomes—Can We REDUCE-IT ?

5. Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Semaglutide functional electrospinning nanofiber membrane rescues apoptosis and promotes diabetic wound healing;European Polymer Journal;2024-11

2. Lipid lowering effects of incretin-based therapies, relevant for cardiovascular benefit?;Current Opinion in Lipidology;2024-07-30

3. Medical weight loss in older persons with obesity;Clinical Obesity;2024-06-26

4. Semaglutide in type 2 diabetes management: review of current evidence from concept to date;FOCUS. Endocrinology;2023-12-27